These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21990269)

  • 61. Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease.
    Oset-Gasque MJ; González MP; Pérez-Peña J; García-Font N; Romero A; del Pino J; Ramos E; Hadjipavlou-Litina D; Soriano E; Chioua M; Samadi A; Raghuvanshi DS; Singh KN; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 74():491-501. PubMed ID: 24502897
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
    Francis PT; Nordberg A; Arnold SE
    Trends Pharmacol Sci; 2005 Feb; 26(2):104-11. PubMed ID: 15681028
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present).
    Wang N; Qiu P; Cui W; Yan X; Zhang B; He S
    Curr Med Chem; 2019; 26(30):5684-5710. PubMed ID: 30501591
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
    Zheng H; Youdim MB; Fridkin M
    J Med Chem; 2009 Jul; 52(14):4095-8. PubMed ID: 19485411
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alzheimer's Drug Discovery Maze: A Snap View of the Past Decade's Diverse Pharmacological Targets for the Disorder.
    Sikazwe D; Yendapally R; Ramsinghani S; Khan M
    Mini Rev Med Chem; 2017; 17(3):305-318. PubMed ID: 27549097
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Retro-enantio N-methylated peptides as beta-amyloid aggregation inhibitors.
    Grillo-Bosch D; Carulla N; Cruz M; Sánchez L; Pujol-Pina R; Madurga S; Rabanal F; Giralt E
    ChemMedChem; 2009 Sep; 4(9):1488-94. PubMed ID: 19591190
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clicked tacrine conjugates as acetylcholinesterase and β-amyloid directed compounds.
    Ouberai M; Brannstrom K; Vestling M; Olofsson A; Dumy P; Chierici S; Garcia J
    Org Biomol Chem; 2011 Feb; 9(4):1140-7. PubMed ID: 21152577
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.
    Jiang H; Wang X; Huang L; Luo Z; Su T; Ding K; Li X
    Bioorg Med Chem; 2011 Dec; 19(23):7228-35. PubMed ID: 22041172
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease.
    Więckowska A; Wichur T; Godyń J; Bucki A; Marcinkowska M; Siwek A; Więckowski K; Zaręba P; Knez D; Głuch-Lutwin M; Kazek G; Latacz G; Mika K; Kołaczkowski M; Korabecny J; Soukup O; Benkova M; Kieć-Kononowicz K; Gobec S; Malawska B
    ACS Chem Neurosci; 2018 May; 9(5):1195-1214. PubMed ID: 29384656
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Galantamine inhibits beta-amyloid aggregation and cytotoxicity.
    Matharu B; Gibson G; Parsons R; Huckerby TN; Moore SA; Cooper LJ; Millichamp R; Allsop D; Austen B
    J Neurol Sci; 2009 May; 280(1-2):49-58. PubMed ID: 19249060
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rational approach to discover multipotent anti-Alzheimer drugs.
    Rosini M; Andrisano V; Bartolini M; Bolognesi ML; Hrelia P; Minarini A; Tarozzi A; Melchiorre C
    J Med Chem; 2005 Jan; 48(2):360-3. PubMed ID: 15658850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bis(7)-tacrine derivatives as multitarget-directed ligands: Focus on anticholinesterase and antiamyloid activities.
    Bolognesi ML; Bartolini M; Mancini F; Chiriano G; Ceccarini L; Rosini M; Milelli A; Tumiatti V; Andrisano V; Melchiorre C
    ChemMedChem; 2010 Aug; 5(8):1215-20. PubMed ID: 20486153
    [No Abstract]   [Full Text] [Related]  

  • 73. [Medicinal and chemical approaches to focused search of agents for treatment and therapy of Alzheimer disease].
    Bachurin SO
    Vopr Med Khim; 2001; 47(2):155-97. PubMed ID: 11450439
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.
    Samadi A; Valderas C; de los Ríos C; Bastida A; Chioua M; González-Lafuente L; Colmena I; Gandía L; Romero A; Del Barrio L; Martín-de-Saavedra MD; López MG; Villarroya M; Marco-Contelles J
    Bioorg Med Chem; 2011 Jan; 19(1):122-33. PubMed ID: 21163662
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer's disease.
    Prati F; Bartolini M; Simoni E; De Simone A; Pinto A; Andrisano V; Bolognesi ML
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6254-8. PubMed ID: 24140444
    [TBL] [Abstract][Full Text] [Related]  

  • 76. N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
    González-Muñoz GC; Arce MP; López B; Pérez C; Romero A; del Barrio L; Martín-de-Saavedra MD; Egea J; León R; Villarroya M; López MG; García AG; Conde S; Rodríguez-Franco MI
    Eur J Med Chem; 2011 Jun; 46(6):2224-35. PubMed ID: 21420206
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Tacrine in Alzheimer's disease].
    López de Munain A
    Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671
    [No Abstract]   [Full Text] [Related]  

  • 78. Design, synthesis, and molecular-modeling study of aminothienopyridine analogues of tacrine for Alzheimer's disease.
    Badran MM; Abdel Hakeem M; Abuel-Maaty SM; El-Malah A; Abdel Salam RM
    Arch Pharm (Weinheim); 2010 Oct; 343(10):590-601. PubMed ID: 20925094
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
    Chen Z; Digiacomo M; Tu Y; Gu Q; Wang S; Yang X; Chu J; Chen Q; Han Y; Chen J; Nesi G; Sestito S; Macchia M; Rapposelli S; Pi R
    Eur J Med Chem; 2017 Jan; 125():784-792. PubMed ID: 27736684
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neuroprotective Effects of Quercetin in Alzheimer's Disease.
    Khan H; Ullah H; Aschner M; Cheang WS; Akkol EK
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.